FLORESTA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 2.722
EU - Europa 2.022
AS - Asia 1.205
SA - Sud America 277
AF - Africa 185
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.419
Nazione #
US - Stati Uniti d'America 2.680
IT - Italia 1.344
SG - Singapore 683
CN - Cina 336
IE - Irlanda 288
BR - Brasile 257
CI - Costa d'Avorio 144
DE - Germania 84
RU - Federazione Russa 59
KR - Corea 56
GB - Regno Unito 38
VN - Vietnam 34
CA - Canada 33
FI - Finlandia 33
CZ - Repubblica Ceca 27
SE - Svezia 27
NL - Olanda 24
FR - Francia 23
UA - Ucraina 22
IN - India 21
BD - Bangladesh 19
SN - Senegal 17
TR - Turchia 12
CH - Svizzera 9
ES - Italia 9
PL - Polonia 8
AT - Austria 7
MX - Messico 7
AR - Argentina 6
AU - Australia 6
NG - Nigeria 6
BE - Belgio 5
EC - Ecuador 5
HK - Hong Kong 5
JP - Giappone 5
MA - Marocco 5
PK - Pakistan 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
IQ - Iraq 4
VE - Venezuela 4
AL - Albania 3
GR - Grecia 3
LB - Libano 3
TN - Tunisia 3
AZ - Azerbaigian 2
CL - Cile 2
CO - Colombia 2
ET - Etiopia 2
JO - Giordania 2
ZA - Sudafrica 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
TW - Taiwan 1
Totale 6.419
Città #
Santa Clara 556
Chandler 439
Singapore 421
Catania 362
Chicago 297
Dublin 288
Civitanova Marche 154
Abidjan 144
Boardman 135
Houston 122
Hefei 121
Ashburn 118
Rome 66
Cambridge 59
Lawrence 59
Naples 55
Seoul 55
Andover 52
Beijing 39
Bremen 39
The Dalles 35
Columbus 34
Nanjing 34
Des Moines 32
Milan 31
San Giovanni la Punta 26
Los Angeles 25
Jacksonville 24
Munich 22
Palermo 22
Brno 21
Council Bluffs 21
Lappeenranta 20
Dong Ket 19
Florence 19
Sala Baganza 18
Dakar 17
São Paulo 17
Toronto 17
Bari 15
Messina 15
Misterbianco 15
Salerno 15
Wilmington 15
Boydton 14
Washington 14
Acireale 12
Porto San Giorgio 11
Saint Petersburg 11
Groningen 10
Hanoi 10
Lecce 10
Villafranca Tirrena 10
Mascalucia 9
San Francisco 9
Dhaka 8
Gravina di Catania 8
Nanchang 8
New York 8
Ottawa 8
Redmond 8
Belo Horizonte 7
Bologna 7
Curitiba 7
Dallas 7
Foggia 7
Hebei 7
Helsinki 7
Jiaxing 7
Paternò 7
Rio de Janeiro 7
Abuja 6
Belpasso 6
Brooklyn 6
Guangzhou 6
Modica 6
Seattle 6
Shenyang 6
Tianjin 6
Turku 6
Villamagna 6
Aci Catena 5
Amsterdam 5
Avola 5
Centro 5
Fortaleza 5
Grafing 5
Ho Chi Minh City 5
Istanbul 5
Jinan 5
Leawood 5
London 5
Manchester 5
Padova 5
Palagonia 5
Phoenix 5
Prague 5
Warsaw 5
Bitonto 4
Bronte 4
Totale 4.501
Nome #
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 124
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 114
Mild Friedel–Crafts Reactions inside a Hexameric Resorcinarene Capsule: C−Cl Bond Activation through Hydrogen Bonding to Bridging Water Molecules 107
[1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor 107
Green efficient one‐pot synthesis and separation of nitrones in water assisted by a self‐assembled nanoreactor 107
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 104
Functionalization of single and multi-walled carbon nanotubes with polypropylene glycol decorated pyrrole for the development of doxorubicin nano-conveyors for cancer drug delivery 101
DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma 99
Carbamoyl-Decorated Cyclodextrins for Carbon Dioxide Adsorption 95
Sigma-2 receptor ligands QSAR model dataset 92
Novel structural insight into inhibitors of heme oxygenase-1 (ho-1) by new imidazole-based compounds: Biochemical and in vitro anticancer activity evaluation 90
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 88
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 87
A pseudouridine isoxazolidinyl nucleoside analogue structural analysis: A morphological approach 87
Design of Small Molecules for Oncological and Neurodegenerative Diseases 85
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 85
Fourfold filtered statistical/computational approach for the identification of imidazole compounds as HO-1 inhibitors from natural products 85
Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis 85
New arylethanolimidazole derivatives as HO-1 inhibitors with cytotoxicity against MCF-7 breast cancer cells 85
Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water 84
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5'-monophosphate glycosidase 82
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 81
Intramolecular oxidative palladium-​catalyzed diamination reactions of alkenyl sulfamates: an efficient synthesis of [1,​2,​5]​thiadiazolo-​fused piperazinones 81
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 79
Ammidi dell’acido rosmarinico come potenziali agenti antidiabetici 79
The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat 77
Computational tools in the discovery of FABP4 ligands: A statistical and molecular modeling approach 77
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 77
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design 77
Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers 76
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2 75
γ-Cyclodextrin as a Catalyst for the Synthesis of 2-Methyl-3,5-diarylisoxazolidines in Water 75
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents 72
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 71
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 70
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia 70
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 69
Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach† 69
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 67
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 67
A Rare Natural Benzo[k,l]xanthene as a Turn-Off Fluorescent Sensor for Cu2+ Ion 67
Development of NO-releasing sigma receptor hybrids as anticancer agents 66
Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose 66
γ-Cyclodextrins as Supramolecular Reactors for the Three-component Aza-Darzens Reaction in Water 65
3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation 64
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors 63
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study 61
FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets 61
H2 production by solar photoreforming of plastic materials using SiC-g-C3N4composites 60
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 60
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes 60
Computer-Assisted Design of Peptide-Based Radiotracers 58
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors 58
Physicochemical characterization and antioxidant activity evaluation of idebenone/hydroxypropyl-β-cyclodextrin inclusion complex 58
Synergic Interplay Between Halogen Bonding and Hydrogen Bonding in the Activation of a Neutral Substrate in a Nanoconfined Space 57
Structural, morphological, and modeling studies of N-(benzoyloxy)benzamide as a specific inhibitor of Type II inosine monophosphate dehydrogenase 56
Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity 55
The hexameric resorcinarene capsule as an artificial enzyme: Ruling the regio and stereochemistry of a 1,3-dipolar cycloaddition between nitrones and unsaturated aldehydes 55
Structure-based approach for the prediction of mu-opioid binding affinity of unclassified designer fentanyl-like molecules 55
A hexameric resorcinarene capsule as a hydrogen bonding catalyst in the conjugate addition of pyrroles and indoles to nitroalkenes 54
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 53
Illuminating the Path to Target GPCR Structures and Functions 53
Metyrapone-β-cyclodextrin supramolecular interactions inferred by complementary spectroscopic/spectrometric and computational studies 53
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 52
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes 52
Supramolecular host-guest interactions of pseudoginsenoside F11 with β- and γ-cyclodextrin: Spectroscopic/spectrometric and computational studies 51
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques 50
Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors 50
Supramolecular biomaterials as drug nanocontainers with iron depletion properties for antimicrobial applications 49
Portable Nanocomposite System for Wound Healing in Space 49
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022 48
c-Met Receptor PET Imaging Probes for Cancer Detection and Monitoring 46
Nature-inspired innovation: Alginic-kojic acid material for sustainable antibacterial and carbon dioxide fixation 45
Evidence of enzyme-mediated transesterification of synthetic cannabinoids with ethanol: potential toxicological impact 45
An integrated pharmacophore/docking/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin a inhibitors 44
Halloysite-kojic acid conjugate: A sustainable material for the photocatalytic CO2 reduction and fixation for cyclic carbonates production 43
Evidence-based successful example of a structure-based approach for the prediction of designer fentanyl-like molecules 41
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process 40
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022 40
Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes 39
Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling 39
How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)? 39
Design and synthesis of novel compounds as fatty acids binding protein inhibitors and as gallium-68 chelators for positron emission tomography 38
Rosmarinic acid amides: synthesis, α-glucosidase inhibition and enzyme binding mode 38
Discovery of high-affinity cannabinoid receptors ligands through a 3D-QSAR ushered by scaffold-hopping analysis 38
Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes 37
HEMA-based macro and microporous materials for CO2 capture 36
Towards identifying nicomorphine administration in doping control: Synthesis of metabolites 36
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach 35
TiO2/Loofah–Halloysite Bio–Hybrid Composites as Efficient Systems for VOCs Removal 35
Recent progress in the imaging of c-Met aberrant cancers with positron emission tomography 35
Solvent-free conversion of CO2 in carbonates through a sustainable macroporous catalyst 34
Current Chemistry behind Peptide-based PET Probes 11C and18F 33
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 32
Machine learning: Vs. field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification 32
Semaglutide as a Possible Calmodulin Binder: Ligand-Based Computational Analyses and Relevance to Its Associated Reward and Appetitive Behaviour Actions 32
Developing Advanced Antibacterial Alginic Acid Biomaterials through Dual Functionalization 32
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis 32
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 31
The synthesis and properties of mitochondrial targeted iron chelators 31
Totale 6.239
Categoria #
all - tutte 26.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.089


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021204 2 4 19 33 55 12 19 8 9 3 23 17
2021/2022486 20 60 27 4 86 6 77 26 38 22 12 108
2022/20231.284 93 80 57 174 107 192 20 183 257 24 68 29
2023/2024915 55 122 69 51 50 185 33 46 33 40 125 106
2024/20253.163 100 455 158 268 511 300 200 150 224 277 251 269
2025/2026163 163 0 0 0 0 0 0 0 0 0 0 0
Totale 6.740